[1]
“Clinical Study Of Neopterin With Cardiovascular Diseases In Iraq Patients”, Journal of Pharmaceutical Negative Results, pp. 5137–5145, Oct. 2022, doi: 10.47750/pnr.2022.13.S08.674.